Brickell Biotech Corporations
Clinical-stage pharmaceutical companyDescription: Brickell Biotech, Inc. is a clinical-stage pharmaceutical company. It is focused on developing prescription therapeutics for treatment of skin diseases. The company's pipeline consists of therapeutics for hyperhidrosis, cutaneous T-cell lymphoma, psoriasis, and other prevalent severe skin diseases.BBI - Brickell Biotech Stock Profile - Barchart.comwww.barchart.com/stocks/quotes/BBI/profile
Technology:
Companies, Corporations
Industry:
AI R&D Pharma (DPI)
Headquarters:
Gisborne, New Zealand
Founded Date:
2009
Register and Claim Ownership